Related Experiment Videos
Pulmonary function in asthmatic children during thalassotherapy
Insights
Thalassotherapy showed clinical improvement in asthmatic children, but pulmonary function tests (PFTs) did not significantly support these findings. While some lung function improved, statistical analysis revealed minimal significant changes in most parameters measured.
Area of Science:
- Pediatric Pulmonology
- Environmental Medicine
- Marine Biology
Background:
- Asthma is a common chronic respiratory disease in children.
- Thalassotherapy, using marine environments, is explored for its therapeutic benefits.
- Objective assessment of thalassotherapy's impact on pediatric asthma is crucial.
Purpose of the Study:
- To evaluate the efficacy of a 6-week thalassotherapy course on pulmonary function in asthmatic children.
- To correlate subjective clinical improvements with objective pulmonary function measurements.
Main Methods:
- Serial pulmonary function studies were conducted on 39 asthmatic children aged 5-14.
- Tested parameters included Vital Capacity (VC), one-second Forced Expiratory Volume (FEV1), Maximal Mid-Expiratory Flow Rate (MMFR), and Peak Flow Rate (PFR).
- Data were analyzed weekly to assess changes over the 6-week course.
Main Results:
- Initial pulmonary function tests revealed subnormal results across all 4 measured parameters.
- Improvements were observed early, generally peaking by week 2.
- Statistical analysis showed insignificant differences between initial and subsequent values, except for FEV1.
Conclusions:
- Clinical improvement in asthmatic children undergoing thalassotherapy was noted.
- Pulmonary function tests did not provide significant statistical substantiation for the observed clinical benefits.
- Further research may be needed to understand the mechanisms and quantify the effects of thalassotherapy in pediatric asthma.
Abstract:
In 39 asthmatic children, 5-14 years of age, sent to the Kinderkurheim Satteldüne for a 6 week course of thalassotherapy, the following pulmonary function studies were tested serially: Vital capacity (VC), one-second forced expiratory volume (FEV1), maximal mid-expiratory flow rate (MMFR) and peak flow rate (PFR). Results expressed as mean values per week of the group as a whole, showed subnormal results at initial testing in all 4 parameters measured. Improvement followed rapidly with the final level generally achieved during week 2. However, statistical analysis showed the differences between the initial and each of the subsequent values to be insignificant with one exception in the FEV1 values. Thus the clinical improvement observed in most patients during thalassotherapy could not be substantiated by pulmonary function tests.